Literature DB >> 15899496

FL-CTL assay: fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells.

Kong Chen1, Liansheng Chen, Peilin Zhao, Luis Marrero, Elizabeth Keoshkerian, Alistair Ramsay, Yan Cui.   

Abstract

Cytotoxic T lymphocytes (CTLs) are crucial effectors against intracellular pathogens and cancer. Accurate and efficient assessment of CTL activity is important for basic and clinical studies. Widely used CTL assays, including the chromium release, JAM test and ELISPOT, involve either radioisotopes or lengthy procedures. Here, we developed a new fluorolysometric CTL assay based on cell-mediated cytolysis of fluorescent protein (GFP or DsRed) expressing cells quantified by one of the fluoro-based methods: flow cytometry, fluorescence microplate reader, or fluorescence microscopy. With flexible detection methods and lentiviral vector transduced stable lines of either GFP+ or DsRed+ cells as targets for antigen presentation and equal number of the other as internal reference for consistency and accuracy, this assay is easy to perform and to scale-up for simultaneous multi-sample analyses. Using two different antigen systems, we demonstrated that this assay is very sensitive to determine primary CTL activity of both in vitro and in vivo primed antigen-specific T cells. Thus, this FL-CTL assay is highly sensitive, reliable, reproducible, economical, convenience and supports broad applications compared to conventional CTL assays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899496     DOI: 10.1016/j.jim.2005.02.010

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

Review 1.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

2.  Controlling influenza by cytotoxic T-cells: calling for help from destroyers.

Authors:  Michael Schotsaert; Lorena Itatí Ibañez; Walter Fiers; Xavier Saelens
Journal:  J Biomed Biotechnol       Date:  2010-05-24

3.  A simple and sensitive method for measuring tumor-specific T cell cytotoxicity.

Authors:  Xinping Fu; Lihua Tao; Armando Rivera; Shana Williamson; Xiao-Tong Song; Nabil Ahmed; Xiaoliu Zhang
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

4.  Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice.

Authors:  Herena Eixarch; Alba Gómez; Elisabeth Kádár; Mónica George; Nuria Martínez; Carmen Espejo; Jordi Pétriz; Ramon Gimeno; Jordi Barquinero
Journal:  Mol Ther       Date:  2009-08-25       Impact factor: 11.454

5.  Treatment of pulmonary metastatic tumors in mice using lentiviral vector-engineered stem cells.

Authors:  X Zhang; P Zhao; C Kennedy; K Chen; J Wiegand; G Washington; L Marrero; Y Cui
Journal:  Cancer Gene Ther       Date:  2007-12-14       Impact factor: 5.987

Review 6.  Immunological assessment of influenza vaccines and immune correlates of protection.

Authors:  Adrian Reber; Jacqueline Katz
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

7.  The functional role of spleen neutrophil-like cells in the immune response to allogeneic tumor cells.

Authors:  E V Maryukhnich; E S Zvezdova; T V Anfalova; L M Khromykh; D B Kazansky
Journal:  Dokl Biol Sci       Date:  2007 May-Jun

8.  A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts.

Authors:  Francesca Bonci; Elisa Zabogli; Francesca Conti; Antonio Merico; Giulia Freer; Mauro Bendinelli; Mauro Pistello
Journal:  BMC Biotechnol       Date:  2009-03-11       Impact factor: 2.563

9.  A simple in vitro method for evaluating dendritic cell-based vaccinations.

Authors:  Phuc Van Pham; Nhung Thi Nguyen; Hoang Minh Nguyen; Lam Tan Khuat; Phong Minh Le; Viet Quoc Pham; Sinh Truong Nguyen; Ngoc Kim Phan
Journal:  Onco Targets Ther       Date:  2014-08-18       Impact factor: 4.147

10.  Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF.

Authors:  Andrea J Manrique-Rincón; Camila M Beraldo; Jessica M Toscaro; Marcio C Bajgelman
Journal:  Front Immunol       Date:  2017-09-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.